Coffee, its legend, history, and influence on human health
Authors:
H. Tesfaye 1; J. Blahoš 2; J. Janatová 1
Authors‘ workplace:
Univerzita Karlova v Praze, 2. lékařská fakulta, Ústav klinické biochemie a patobiochemie, oddělení klinické farmakologie FN Motol
1; ÚVN Praha, Oddělení klinické endokrinologie a osteocetrum
2
Published in:
Čas. Lék. čes. 2009; 148: 39-42
Category:
Special Articles
Overview
In the introductory part of this article the history /legend of coffee as well as its spread to different parts of the world including Europe is discussed. Data sofar available in literature do not give any convincing evidence regarding clear relationship between coffee and the etiopathogenesis of several diseases including diabetes mellitus type 2, cardiovascular diseases, gout, osteoporosis, neurologic disorders and colorectal cancer. Favorable (protective) effects of coffee consumption against hepatocellular cancer have been repeatedly described. The autors discuss on todate findings about relationship between blood cholesterol and uric acid in literature and remind their own experience with different population groups in Harar, Ethiopia, where consumption of coffee is habitual in daily life of the inhabitants.
Key words:
coffee, history, effect on health, coffee in Ethiopia.
Sources
1. Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: Mechanism of action, biochemical, metabolic, and psychostimulant effects. Brain Res Rev 1992; 17: 139–170.
2. Gross G, Jaccaud E, Nuggety AC. Analysis of the content of the diterpenes cafestol and kahweol in coffe brews. Food Chem Toxicol 1997; 35: 547–554.
3. Perlík F, Pučelíková T, Slanař O. Použití poměru paraxantinu-kofeinu ve slinách nemocných jaterní cirhózou. Čas Lék čes 2001; 140: 51–53.
4. Bidel S, Hu G, Sundvall J, Tuomilehto L. Effects of coffee consumption on glucose tolerance, serum glucose, and insulin levels: a cross-sectional analysis. Horm Metab Res 2006; 38: 38–43.
5. Campos H, Baylin A. Coffee consumption and risk of type 2 dibetes and heart disease. Nutr Rev 2007; 65: 173–179.
6. Panagiaotakos DB, Lionis C, Zeimbekis A, Makri K, et al. Long-term moderate coffee consumption is associated with lower prevalence of diabetes mellitus among elderly non-tea drinkers from the mediteranian islands (MEDIS Study). Rev Diabet Stud 2007; 4: 105–111.
7. MacKenzie T, Comi R, Sluss P, Keisari R, et al. Metabolic and hormonal effects of caffeine: randomized, double-blind, placebo-controlled crossover trial. Metabolism Clinical and Experimental 2007; 56: 1694–1698.
8. Du Y, Melchert HU, Knopf H, Braemer-Hauth M, Pabel E. Association of serum caffeine concentrations with serum glucose levels in caffeine-drug users and non-users –results of German National Health Surveys. Diabetes Obes Metab 2007; 9: 756–758.
9. Van Dam RB, Willett WC, Mansson JE, Hu FB. Coffee, caffeine, and risk of type 2 diabetes. Diabetes Care 2006; 29: 398–403.
10. Jane JD, Hwang AL, Feinglos MN, Surwit RS. Exaggeration of postprandial hyperglycemia in patients with type 2 diabetes by adminstration of caffeine in coffee. Endocr Pract 2007; 13: 239–243.
11. Shearer J, Sellars EA, Farah A, Graham TE, and Wasserman DH. Effects of chronic coffee consumption on glucose kinetics in conscious rat. Can J Physiol Pharmacol 2007; 85: 823–830.
12. Bidel S, Hu G, Quiao Q, Jousilahti P, Antikainen R, Tuomilehto J. Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes. Diabetologia 2006; 49: 2618–2626.
13. Sofi F, Conti AA, Gori AM, et al. Coffee consumption and risk of coronary heart disease: a meta-analysis. Nutr Metab Cardiovasc Dis 2007; 17: 209–223.
14. Lopez-Garcia E, van Dam RM, Willett WC, et al. Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation 2006; 113: 2045–2053.
15. Karatzis E, Papaioannou TG, Aznaouridis K, et al. Acute effects of caffeine on blood pressure and wave reflections in healthy subjects: Should we consider monitoring central blood pressure? Int J Cardiol 2005; 98: 425–430.
16. Happonen P, Voutilainen S, Salonen JT. Coffee drinking is dose-dependently related to risk of acute coronary events in middle-aged men. J Nutr 2004; 134: 2381–2386.
17. Bonita JS, Mandarano M, Shuta D, Vinson J. Coffee and cardiovascular disease: ln vitro, cellular, animal, and human studies. Pharmacological research 2007; 55: 187–198.
18. Cavin C, Holzhaeuser D, Scharf G, Constable A, Hubert WW, Shilter B. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 2002; 40: 1155–1163.
19. Vyskočil F. Káva vcelku blahodárná. Vesmír 2007; 86: 92–97.
20. Sun Ha Jee, Jiang He, Paul K, et al. The effect of chronic coffee drinking on blood pressure: A meta-analysis of controled clinical trials. Hypertension 1999; 33: 647–652.
21. Uiterwaal Cuno SPM, Verschuren WMM, Bueno de-Mesquita HBS, et al. Coffee intake and incidence of hypertension. Am J Clin Nutr 2007; 85: 718–723.
22. Choi HK, Willett W, Curhan G. Coffee, Tea, and caffeine Consumption and risk of incident gout in men: A prospective Study. Arthritis & Rheumatism 2007; 56: 2049–2055.
23. Blahoš J. Kyselina močová, její metabolismus a patogenetický význam. Thomayerova sbírka č. 466 Praha: Szdn 1968; 91–93.
24. Blahoš J, Reisenauer R. Levels of serum uric acid and serum cholesterol in various groups in Ethiopia Amer. J Med Sci 1965; 250: 308–314.
25. Rapuri PB, Gallagher JC, Navaz Z. Coffeine decreases vitamin D receptor protein expression and 1,12 (OH2) D3 stimulated alkaline phosphatase aktivity in human osteoblast cells. J Steroid Biochem Mol Biol 2007; 103: 368–371.
26. Halstrom H, Wolk A, Glynn A, Michaelson K. Coffee, Tea, and Caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women. Osteoporos Int 2006; 17: 1055–1064.
27. Barranco Quintana JL, Allam MF, Serrano Del Castillo A, Fernández-Crehuet Navajasi R. Alzheimer’s disease and coffee: a quantitative review. Neurol Res. 2007; 29: 91–95.
28. Bonilha L, Li ML. Heavey coffee drinking and epilepsy. Seizure 2004; 13: 284–285.
29. Larsson SC, Bergkvist L, Giovannucci E, Wolk A. Coffe consumption and incidence of colorectal cancer in two prospective cohort studies of Swedish women and men. Am J Epidemiol 2006; 163: 638–644.
30. Lee KJ, Inoue M, Otani T, Iwasaki M, Saskazuki S, Tsugane S, JPHC Study Group. Coffee consumption and risk of colorectal cancer in a population-based prospective cohort of Japanese men and women. Int J Cancer 2007; 121: 1312–1318.
31. Giovannucci F. Meta-analysis of coffee consumption and risk of colorectal cancer. Am J Epidemiol. 1998; 147: 1043–1052.
32. Larsson SC, Wolk A. Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology 2007; 132: 1740–1745.
33. Kerrigan S, Lindsey T. Fatal caffeine overdose: Two case reports. Forensic Science International 2005; 153: 67–69.
34. De Roos B, van der Weg G, Urgent R, van de Bovenkamp P, Charrier A, Katan MB. Levels of cafestol, kahweol, and related diterpenoids in wild species of the coffe plant coffea. J Agric Food Chem 1997; 45: 3065–3069.
35. Blahoš J, Kubaštová B. The survey of 11,170 patients treated in the Ras Makonnen Hospital in Harar. Etiop Med J 1963; 1: 190–196.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistArticle was published in
Journal of Czech Physicians
Most read in this issue
- Fatty acids – 1. Occurrence and biological significance
- Osteoporosis: Whom, when and how to treat?
- Coffee, its legend, history, and influence on human health
- Nitric oxide in patients with obesity and metabolic syndrome